|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1995-4-27
|
|
pubmed:abstractText |
Elderly patients with small cell lung cancer (SCLC) and/or those with comorbid conditions are frequently not considered candidates for standard combination chemotherapy. An active, but less toxic regimen is needed for this group of patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0277-3732
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
149-55
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:7534977-Aged,
pubmed-meshheading:7534977-Aged, 80 and over,
pubmed-meshheading:7534977-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7534977-Carboplatin,
pubmed-meshheading:7534977-Carcinoma, Small Cell,
pubmed-meshheading:7534977-Combined Modality Therapy,
pubmed-meshheading:7534977-Etoposide,
pubmed-meshheading:7534977-Female,
pubmed-meshheading:7534977-Frail Elderly,
pubmed-meshheading:7534977-Humans,
pubmed-meshheading:7534977-Lung Neoplasms,
pubmed-meshheading:7534977-Male,
pubmed-meshheading:7534977-Middle Aged,
pubmed-meshheading:7534977-Palliative Care,
pubmed-meshheading:7534977-Remission Induction,
pubmed-meshheading:7534977-Survival Rate
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Oral etoposide and carboplatin. Effective therapy for elderly patients with small cell lung cancer.
|
|
pubmed:affiliation |
University of Ottawa, Ontario, Canada.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
